Skip to Main Content

Author Details

Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
2003
109
46
PMIDPaper TitleJournal TitlePublished Year
36938641Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.Cancer Cytopathol2023
37927461Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.Front Oncol2023
37970806Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis.Mol Pharm2023
37479706Obesity-associated changes in molecular biology of primary breast cancer.Nat Commun2023
37405466Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA).Lung2023
36868206Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.Am J Hum Genet2023
36938641Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.Cancer Cytopathol2023
37479706Obesity-associated changes in molecular biology of primary breast cancer.Nat Commun2023
37927461Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.Front Oncol2023
37970806Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis.Mol Pharm2023
37405466Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA).Lung2023
36868206Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.Am J Hum Genet2023
35057759Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.BMC Cancer2022
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
36147610Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield.JTO Clin Res Rep2022
35008424Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients.Cancers (Basel)2022
35057759Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.BMC Cancer2022
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
36147610Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield.JTO Clin Res Rep2022
35008424Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients.Cancers (Basel)2022
33413533Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.Breast Cancer Res2021
34064871Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.Biology (Basel)2021
33919581The Genomic Landscape of Lobular Breast Cancer.Cancers (Basel)2021
33413533Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.Breast Cancer Res2021
34439402Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 1950.Cancers (Basel)2021
33919581The Genomic Landscape of Lobular Breast Cancer.Cancers (Basel)2021
34439402Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. <i>Cancers</i> 2021, <i>13</i>, 1950.Cancers (Basel)2021
34064871Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.Biology (Basel)2021
32458049Digital spatial profiling application in breast cancer: a user's perspective.Virchows Arch2020
32244556Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer.Cancers (Basel)2020
32458049Digital spatial profiling application in breast cancer: a user's perspective.Virchows Arch2020
32818150Using whole-genome sequencing data to derive the homologous recombination deficiency scores.NPJ Breast Cancer2020
33363813Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.Clin Case Rep2020
32527287Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.Breast Cancer Res2020
32633764Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.JAMA Netw Open2020
33014146Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastases.Ther Adv Med Oncol2020
33276802Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.Breast Cancer Res2020
32939056Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.Br J Cancer2020
33276802Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.Breast Cancer Res2020
33363813Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.Clin Case Rep2020
32633764Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.JAMA Netw Open2020
32939056Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.Br J Cancer2020
32818150Using whole-genome sequencing data to derive the homologous recombination deficiency scores.NPJ Breast Cancer2020
33014146Clinicopathologic significance of nuclear HER4 and phospho-YAP(S<sup>127</sup>) in human breast cancers and matching brain metastases.Ther Adv Med Oncol2020
32527287Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.Breast Cancer Res2020
32244556Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer.Cancers (Basel)2020
29398118Corrigendum to "Molecular signatures in breast cancer" [Methods 131 (2017) 135-146].Methods2019
30350370Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.J Pathol2019
30246500Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.J Pathol Clin Res2019
29398118Corrigendum to "Molecular signatures in breast cancer" [Methods 131 (2017) 135-146].Methods2019
  • 1 - 50 of 218

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 2
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 7
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 4
Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 13
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year 2009
Number of shared co-authors 9
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 17
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 6
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 8
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 11
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year 2006
Number of shared co-authors 7
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 6
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 12
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 18
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 18
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 8
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 3
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 10
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 2
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 0
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 15
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 19
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 8
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 10
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 18
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

Sunil R Lakhani
University of Queensland
Co-authored papers 89
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 27
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 24
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Co-authored papers 21
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 20
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 16
Chris Jones
Co-authored papers 11
Alan Mackay
Co-authored papers 9
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers 9
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers 8
Sean M Grimmond
The University of Melbourne
Co-authored papers 7
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Co-authored papers 7
Andrea L Richardson
Co-authored papers 6
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 6
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 6
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 6
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 5
Ewan Birney
European Bioinformatics Institute
Co-authored papers 5
Dominik Glodzik
Co-authored papers 5
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers 5
Paul N Span
Radboud University Medical Center
Co-authored papers 5
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 5
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 4
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 4
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 3
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Lachlan J M Coin
The Peter Doherty Institute for Infection and Immunity, The University of Melbourne
Co-authored papers 3
Kim-Anh L?? Cao
University of Melbourne
Co-authored papers 3
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 3
Release 1.2